U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays
3 minute readPublished: Wednesday, October 12, 2022 at 9:38 pm
/cloudfront-us-east-2.images.arcpublishing.com/reuters/DTGEASS5YRPFDLG672245HDV7E.jpg)
The U.S. Food and Drug Administration said on Wednesday there was a shortage of Adderall, a treatment for attention deficit hyperactivity disorder, following intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd.